Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Rochester, Minnesota 55905


Purpose:

Objectives: - To obtain clinical evidence for the safety and efficacy in using the StabilAir Wrist Fracture Brace for the following cases: 1. Acute (emergency department) treatment of non-displaced, stable extra- articular distal radius fractures; 2. To obtain comparative data between traditional therapies (sugar tong, plaster backslab, long arm or short arm cast) and the use of the StabilAir brace for each patient qualified by specific criteria. This will provide a complete cost-of-care analysis from one modality to the other. Hypothesis: 1) For stable, non-displaced fractures, the StabilAir Brace is as effective as a sugar tong splint in the acute setting. 2) In cases where full forearm immobilization is initially preferred, the StabilAir is effective as a follow-up to sugar tong splitting once the need for full immobilization has passed. The benefit of utilizing a product of this type in the acute or follow-up setting is that it is an adjustable fit, "off-the-shelf" device, which can be quickly and comfortably applied to the patient. It can then transition effectively to be the product of choice for the remainder of treatment through rehabilitation since it will protect, stabilize, and support the injury while adapting to changing patient conditions and needs. Because it is removable (late but not early in fracture core period) there are potential benefits to comfort and hygiene. Therefore, the total cost of care is reduced by using one product from the progress of the injury to fracture reduction and through to recovery (rather than a variety of products that require investment in materials, time, and personnel for cast changes and potential fracture re-reduction. In the initial treatment period, the StabilAir Brace will be firmly held in place by a peripheral "guard wrap" and will only be removed under the supervision of the treating surgeon. Only when clear evidence of fracture healing is present would the patient be allowed to physically remove the brace.


Study summary:

Data Collection and Study Design: This will be a single center, prospective, randomized controlled trial. We will collect data from 80 patients with undisplaced distal radius fractures. Half will be treated with the plastic back slab or sugar tong splint (if there is ulnar styloid fracture) and half will be treated with the StabilAir splint. The initial treatment, which occurs upon the patient's arrival at the emergency room and prior to study randomization, will require full forearm and wrist immobilization in the acute phase treated with sugar tong splinting. At the patient's follow-up visit, which will happen ≤10 days post injury and initial evaluation, when it is determined that full forearm immobilization is no longer necessary, patients will be informed of the study, consented, and randomized (as in the flip of a coin) to one of the two study groups using a computerized randomization process that will be controlled by the study coordinator. One study group will consist of patients that are treated with either sugar tong splint or plaster casting and the other study group will consist of patients treated with the StabilAir brace. Throughout entire study, the sugar tong splint/casting patients will be the control group. Patients will be asked to return for the following visits after they are randomized: - 10-14 days post randomization - 35 to 42 days (5 to 6 weeks) post randomization - 77 to 84 days (11 to 12 weeks) post randomization; - And at 12 and 24 months At each visit they will have x-rays of their wrist and an exam with the physician. In addition, they will be asked to complete the DASH and PRWE questionnaires regarding their general health, daily activities and pain. The decision for treatment will be made using the LaFontaine criteria. If there is a combination of 3 or less LaFontaine criteria (displacement, comminution, distal radio-ulnar joint injury, age >60 years), and no intra-articular involvement, then the patient fits criteria for inclusion. Exclusion criteria include intra-articular fractures, excessive comminution, open fractures, and failed closed reduction of the fracture requiring open reduction. Patients with loss of reduction requiring secondary treatment will be excluded. Assessment of Results: The results of treatment will be assessed by clinical, radiographic and patient assessment criteria. Clinical objective assessment will be performed by the Gartland-Werley score and Mayo Wrist Score. Radiographic assessments were made by the Stewart Score and measures of dorsal angulation, radial shortening, radio-ulnar test. Functional scores will include the DASH (disabilities arm, shoulder, hand) and PRWE (patient related wrist evaluation). Acute Care (ED) Nondisplaced and/or No Forearm Immobilization Required Outcome Measurements: - Initial displacement vs position of distal fragment at 8 weeks (Bunger et al. method) - End fragment position of StabilAir brace patients vs traditionally treated patients - Statistical comparison with paired T-test. We will be comparing radiographic parameters (intrarticular or displaced, Dorsal angulation , Shortening, radial inclination), and outcome scores from the DASH and PRWE to identify any significant differences based upon an n = 40. We predict assuming a two-sample t-test is used to compare the two arms, you will have 80% power to detect an effect size of 0.90 (almost 1 SD). Materials: - StabilAir Wrist fracture orthoses - Stockinets (extra supply for subsequent application to patient) - Hand-bulb and pressure gauge - Patient data collection forms - initial and follow-up - Cast and sugar tong materials - Patient surveys Patient Inclusion Criteria: - Males and Females Age ≥ 18 yrs - Undisplaced distal radial fractures (with/without ulnar styloid fractures) Patient Exclusion Criteria: - Age < 18 yrs - Intra-articular fracture - displaced - Loss of reduction after cast or brace treatment - Excessive comminution (> 50% metophysis) - Failed closed reduction (Unacceptable alignment s/p CR: Short >2mm; Dorsal angulation >0° (neutral), Radial inclination < 15°) - Ipsilateral ulna fractures (not styloid) - Open fracture - Senile or dementia or lack of understanding of treatment - Previous fracture distal radius - Patients with displaced fractures that require pin fixation, external fixation, plate fixation or who qualify for "crystalline injection fracture healing protocol" are excluded from the study Results Tabular format to show: 1. Anatomical scores (radiographic scores - Stewart) 2. Functional scores (DASH, PRWE) 3. Objective motion and grip strength 4. Wrist scores (Mayo or Krimmer wrist score) 5. Summarize statistical trends. Discussion: Do the results agree with or support the hypothesis? Is there a clear difference between treatment types? Is there potential for loss of reduction quotes with use of an aircast brace? Is there a greater number of patients converted over from standard cast or sugar tong splint treatment to ORIF vs external fixation (assuming similar fracture stability criteria) in compression to the Aircast Stabilair Brace? Positive feedback indicating benefits to patient's clinical outcome and level of comfort and hand functional use comparing cast treatment vs bracing.


Criteria:

Inclusion Criteria: - Males and Females Age ≥ 18 yrs - Undisplaced distal radial fractures (with/without ulnar styloid fractures) Exclusion Criteria: - Age < 18 yrs - Intra-articular fracture - displaced - Loss of reduction after cast or brace treatment - Excessive comminution (> 50% metophysis) - Failed closed reduction (Unacceptable alignment s/p CR: Short >2mm; Dorsal angulation >0° (neutral), Radial inclination < 15°) - Ipsilateral ulna fractures (not styloid) - Open fracture - Senile or dementia or lack of understanding of treatment - Previous fracture distal radius - Patients with displaced fractures that require pin fixation, external fixation, plate fixation or who qualify for "crystalline injection fracture healing protocol" are excluded from the study


NCT ID:

NCT00587795


Primary Contact:

Principal Investigator
David G Dennison, MD
Mayo Clinic


Backup Contact:

N/A


Location Contact:

Rochester, Minnesota 55905
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.